Allurion Technologies, Inc. Increase (Decrease) in Inventories
Allurion Technologies, Inc. (ALUR) reported Increase (Decrease) in Inventories of -$176.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-05-15
- Allurion Technologies, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$176.00K.
- Allurion Technologies, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$278.00K, a 3575.00% decline year-over-year.
- Allurion Technologies, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$53.00K, a 111.45% decline year-over-year.
- Allurion Technologies, Inc. increase (decrease) in inventories for the quarter ending 2025-06-30 was $839.00K.
- Allurion Technologies, Inc. increase (decrease) in inventories for fiscal 2025 was $486.00K.
- Allurion Technologies, Inc. increase (decrease) in inventories for fiscal 2024 was -$543.00K, a 114.66% decline from fiscal 2023.
- Allurion Technologies, Inc. increase (decrease) in inventories for fiscal 2023 was $3.71M, a 222.17% increase from fiscal 2022.
- Allurion Technologies, Inc. increase (decrease) in inventories for fiscal 2022 was $1.15M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$176.00K 10-Q · filed 2026-05-15 | -$454.00K derived: sum of 2 quarters · filed 2026-05-15 | -$507.00K derived: sum of 3 quarters · filed 2026-05-15 | $332.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -$278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$331.00K derived: sum of 2 quarters · filed 2026-03-30 | $508.00K derived: sum of 3 quarters · filed 2026-03-30 | $486.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $786.00K derived: sum of 2 quarters · filed 2025-11-17 | $764.00K 10-Q · filed 2025-11-17 | $772.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $839.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $817.00K 10-Q · filed 2025-08-19 | $825.00K derived: sum of 3 quarters · filed 2026-05-15 | $1.29M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | -$22.00K 10-Q · filed 2026-05-15 | -$14.00K derived: sum of 2 quarters · filed 2026-05-15 | $449.00K derived: sum of 3 quarters · filed 2026-05-15 | -$235.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $471.00K derived: sum of 2 quarters · filed 2026-03-30 | -$213.00K derived: sum of 3 quarters · filed 2026-03-30 | -$543.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $463.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-17 | -$221.00K derived: sum of 2 quarters · filed 2025-11-17 | -$551.00K 10-Q · filed 2025-11-17 | $2.25M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$684.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | -$1.01M 10-Q/A · filed 2025-08-28 | $1.79M derived: sum of 3 quarters · filed 2025-08-28 | $1.22M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | -$330.00K 10-Q/A · filed 2025-08-28 | $2.48M derived: sum of 2 quarters · filed 2025-08-28 | $1.91M derived: sum of 3 quarters · filed 2025-08-28 | $2.93M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | $2.81M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $2.24M derived: sum of 2 quarters · filed 2025-08-28 | $3.26M derived: sum of 3 quarters · filed 2025-08-28 | $3.71M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | -$569.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28 | $450.00K derived: sum of 2 quarters · filed 2025-08-28 | $899.00K 10-Q/A · filed 2025-08-28 | $453.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | $1.02M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | $1.47M 10-Q/A · filed 2025-08-28 | $1.02M derived: sum of 3 quarters · filed 2025-08-28 | $1.83M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | $449.00K 10-Q/A · filed 2025-08-28 | $3.00K derived: sum of 2 quarters · filed 2025-08-28 | $810.00K derived: sum of 3 quarters · filed 2025-08-28 | |
| 2022-12-31 | -$446.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $361.00K derived: sum of 2 quarters · filed 2025-08-28 | $1.15M 10-K/A · filed 2025-08-28 | |
| 2022-09-30 | $807.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.60M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $789.00K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |